Aclarion Reports Q3 Growth and Trial Progress
The Broomfield-based company highlighted an 85% year-over-year increase in scan volume during the third quarter of 2026.
Live Poll
Do you trust that health tech companies prioritize long-term clinical patient outcomes over short-term financial targets?
